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The successful isolation and cultivation of Lyme disease spirochetes traces its lineage to early
attempts at cultivating relapsing fever borreliae. Observations on the growtlh of Lyme disease
spirochetes under different in vitro conditions may yield important clues to botlh the metabolic
characteristics of these newly discovered organisms and the pathogellesis of Lyme disease.
The isolation and in vitro cultivation of hitherto unknown spirochetes first from
ixodid ticks [1,2] and then from mammals [3,4] and patients with Lyme disease [5-7]
was an advance that was built upon a substantial foundation provided by other in-
vestigators. A distant connection exists to the attempts by Noguchi at the Rocke-
feller Institute to cultivate pathogenic spirochetes. Although the treponeme he even-
tually propagated was not, in retrospect, Treponemapallidum [8,9], it is clear that
in his laboratory relapsing fever borreliae could be maintained, at the very least, in
vitro and probably did multiply for several generations [10]. His medium for bor-
reliae had as its base human ascitic fluid, which to be optimally conducive to bor-
relial growth had to be free of bile, high in protein content, and capable of produc-
ing a disperse fibrin net upon addition of citrated blood [10,1 ]. These observations
may have anticipated the exquisite sensitivity of borreliae to detergents [12] and the
need for albumin and a thickening agent such as gelatin in latter-day media for-
mulations [2,13,14].
In 1922 Kligler and Robertson, also at the Rockefeller Institute, extended the
research on borrelial cultivation by defining the conditions for maintenance and
growth of these spirochetes in derivatives of Noguchi's medium [15]. These investi-
gators found, for instance, that rabbit or horse serum, even when diluted, could
substitute for human ascitic fluid and that growth effectively occurred only between
pH 7 and 8. To "stabilize" the pH, Kligler and Robertson added peptone water or
egg albumin as "buffer." The salutariness of these additives may have been as much
from the additional nutrients they supplied as from their buffering capacities. The
two workers also identified borreliae as aerobes and noted that the constancy of the
carbon dioxide concentration was important.
Although there were many other attempts in the subsequent half century to prop-
agate borreliae continuously, these efforts were, for the most part, based upon the
animal sera and protein-rich fluids that had been identified earlier. Felsenfeld in his
1971 review ofthis subject may have been prescient when he said, regarding borrelial
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cultivation: "There is little hope that any ofthese methods could be usedsuccessfully
in routine diagnostic laboratories. Further investigations may lead to the develop-
ment of more feasible methods" [16]. For it was in the publication year of Felsen-
feld's monograph that Kelly reported the breakthrough of successful propagation of
Borrelia hermsii through many passages [13]. Kelly's medium had some of the ele-
ments of previous recipes. In addition, however, it contained an adequate buffer
system, other salts, glucose, pyruvate, gelatin, sodium bicarbonate, and what I think
may have been the single most critical ingredient, N-acetylglucosamine, a building
block of bacterial peptidoglycan.
Although Kelly's medium provided a suitable environment for hundreds of
generations ofborreliae, Stoenner noted in 1974 that this medium could not support
the growth of blood culture inocula containing less than 800 spirochetes [17]. To
find a medium that would allow the multiplication of one mouse-virulent borrelia
into a large population, Stoenner enriched the basic formulation of Kelly. The sup-
plements that permitted cloning of B. hermsii were Yeastolate in concert with
CMRL 1066, a tissue culture medium containing amino acids, vitamins, and other
growth factors [14].
It was from Dr. Stoenner that I learned the science and art of cultivating bor-
reliae, and it was on November 13, 1981, that another colleague at the Rocky Moun-
tain Laboratories, Dr. Willy Burgdorfer, provided me with a pool of midguts from
Ixodes dammini ticks collected on Shelter Island, New York, by Dr. Jorge Benach
and co-workers. I placed the spirochete-containing tissues in the "fortified Kelly's
medium" of Stoenner [14] and ground the tissues. Tenfold dilutions of the suspen-
sion were made in this medium, and the capped tubes were incubated at 35°C. On
November 18, the following was recorded in the lab notebook: "[tubes] #4, 5, 6 all
have spirochetes! Borrelia-like." During the next two weeks I tried to rid the culture
ofits contaminating gram-positive rod and an actinomycete-like bacterium. I found
that the spirochete was resistant to 100 Ag and 200 Ag per ml of, respectively, nali-
dixic acid and 5-fluorouracil and that these agents suppressed the growth ofthe con-
taminants and allowed indirect immunofluorescence assays to be performed with
sera collected by Dr. Edgar Grunwaldt on Shelter Island. Shortly thereafter, I noted
that cultures containing the 1-to-10,000 and 1-to-100,000 dilutions also showed
growth of the unknown spirochetes and that these cultures were free of bacterial
contaminants [1]. This original Shelter Island isolate was cloned from the 1-to-
100,000 dilution culture by limiting dilution. One ofthe clones was designated strain
B31 (ATCC 35210; 2).
Attempting to improve the medium and the ease of its production, I made some
changes. One of the new formulations was used to isolate from Ixodes ricinus ticks
of Switzerland a spirochete that was practically identical to the I. dammini spiro-
chete [2]. This European spirochete (ATCC 35211) was cloned by limiting dilution in
the now-named BSK medium [2].
The latest modification, BSK II, is described in Table 1. This medium differs from
the original BSK (BSK I) in the deletion ofglutamine from CMRL 1066 and addition
of Yeastolate. Although many of the ingredients in BSK I1, e.g., citrate, pyruvate,
gelatin, CMRL 1066, Yeastolate, and even serum (vide infra) may not be essential
for growth of the Lyme disease and ixodid tick spirochetes, we have found in our
laboratory that only the complete medium suffices for reliable achievement ofspiro-
chete densities of 1-4 x 108 per ml, generation times ofapproximately 11-12 hours,
and growth of cultures from inocula of one to two organisms. We also use BSK 11
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TABLE 1
Formulation of BSK I1 Medium
1. After detergent cleaning, all glassware is rinsed thoroughly with glass-distilled water and theni auto-
claved.
2. To 900 ml of glass-distilled water are added 100 ml of lOX concentrate of CMRL 1066 without gluta-
mine (Gibco Laboratories, Grand Island, NY, No. 330-1540).
3. Add to the IX CMRL 1066 in the following order: 5 g Neopeptone (Difco Laboratories, Detroit, Ml);
50 g bovine serum albumin, Fraction V (Miles Laboratories, Elkhart, IN, No. 81-003); 2 g Yeastolate
(Difco); 6 g N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES, Sigma Chemical Co., St.
Louis, MO); 5 g glucose; 0.7 g sodium citrate; 0.8 g sodium pyruvate; 0.4 g N-acetylglucosamine
(Sigma); and 2.2 g sodium bicarbonate.
4. Adjust pH of medium at 20-25°C to 7.6 with 1 N NaOH.
5. Add 200 ml of 7 percent gelatin (Difco) which had been dissolved in boilinig water.
6. Sterilize by filtration with air pressure (0.2 ltm nitrocellulose, Millipore Corp., Bedford, MA). Store
medium at 4°C.
7. Before use, add unheated rabbit serum ("trace hemolyzed"; Pel-Freez Biologicals, Inc., Rogers, AR)
to a final concentration of 6 percent.
8. Dispense to glass or polystyrene tubes or bottles. Fill containers to 50 to 90 percent capacity anid cap
tightly.a
9. Incubate at 34-37°C.
aHamilton, Montana, is at an altitude of 1,200 m. At lower elevationis the containiers may nieed to be
filled to a higher level.
for growing virulent strains of some of the relapsing fever borreliae. These latter
spirochetes are even less tolerant of subtractions or modifications of the BSK 11
medium than are the Lyme disease spirochetes, and so, for practical reasons, we
continue to use this rather complex concoction.
Undoubtedly, useful simplifications of the medium for Lyme disease spirochete
cultivation will be discovered, certainly as more is learned of the metabolism and
growth requirements ofthese organisms. On the other hand, insights into these fun-
damental characteristics of the spirochetes may come also from observations of
what empirically works in a medium and what does not. For example, I found that
RPMI 1640, a tissue culture formulation less complex than CMRL 1066, could be
substituted for the latter supplement in the cultivation of Lyme disease spirochetes
but not that of relapsing fever borreliae. Likewise, Brain Heart Infusion broth with
0.5 percent Casamino acids and a salts solution could serve as a replacement for
both CMRL 1066 and Neopeptone in the BSK II formulation and allow satisfactory
growth of strain B31. However, this altered medium was unsatisfactory for prop-
agation of B. hermsii [Barbour AG: unpublished observations]. Following up the
discovery by Rothenberg, Kaplan, and co-workers [Kaplan M: personal communi-
cation] that Lyme disease spirochetes could be grown in BSK II medium without
serum, I found that was indeed possible with some sources of Fraction V of bovine
serum albumin (e.g., Sigma A4503) but not with bovine albumin of higher grade
(e.g., Miles Laboratories 81-003) as assessed by the albumin content given in the
product's specifications [Barbour AG: unpublished observations]. As in the ex-
amples given above, B. hermsii, in contrast to Lyme disease spirochetes, grew poorly
in the absence of serum.
A few additional observations during the two years my laboratory has been cul-
tivating Lyme disease spirochetes and altering the growth conditions may have rele-
523vance to the pathogenesis of erythema chronicum migrans, tick-borne meningo-
radiculitis, and Lyme arthritis.
First, strain B31 grew both within and as a "lawn" on a BSK I medium solidified
with 0.8 percent agarose. The tubes ofmedium were incubated in 10 percent carbon
dioxide and the plates were incubated in a candle jar [Barbour AG: unpublished
observations]. This capability to grow in solid medium may denote a potential for
these spirochetes to grow in tissues as well as in body fluids. Indeed, spirochetes
have been seen in and recovered from skin biopsies of erythema chronicum migrans
lesions [5,7].
Second, the optimum temperature for in vitro cultivation of Lyme disease spiro-
chetes is between 30-37°C. At 39°C, growth is slower and long filamentous forms
appear. At temperatures of40°C and above, growth does not occur at all, and spiro-
chetes kept at this temperature do not seem capable of multiplying even when the
temperature is lowered [Barbour AG: unpublished observations]. Such temperature
maxima of around 40°C may explain the localization ofthese organlisms in the skin,
a cooler region ofthebody. It may also indicate that in vivo growth is not possible in
some animals with relatively high core temperatures.
r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~.~ ~~~~~~~~~~~~~~Z...... .
FIG. 1. Aggregation of Lyme disease spirochetes during in vitro cultivation. A. Large aggregates
of strain HBI9 spirochetes (human blood isolate from [5]) at bottom of culture bottle containling BSK 11
medium. Arrow indicates an aggregate and its chlaracteristic "branch.es." B. Phase contrast photo-
micrograph of early passage of the Ixodes ricinus spirochlete [2]. A small aggregate is shlown. Bar, 10 zm.
C. Scanning electron photomicrograph of aggregate of a field mouse spirochete isolate (strain 50-2; [3]).
An aggregate similar to the one shown in frame A was carefully removed from the bottom of a culture
bottle, fixed in glutaraldehyde, post-fixed in osmium tetroxide, dehlydrated in ethanlol, critically point-
dried in carbon dioxide, and sputtered coated with gold. The figure shlows a tangle of spirochetes, many
of which have outer membrane blebs. Bar, I tim. D. Scannling electron photomicrographl. Thle same
specimen as in frame C was prepared as described above. Thle arrow indicates an outer membranle bleb.
Bar, 1 zm.
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Finally, I have been intrigued by the tendency of the Lyme disease spirochetes in
the initial isolations and through their early subpassages to grow in large aggre-
gates [2]. Examples of those aggregations viewed both macroscopically and
microscopically are shown in Fig. 1. Following dispersion of the clumps by vortex-
ing or pipetting, they rapidly reassemble. Many of the strains after several subpass-
ages no longer aggregate and instead swim free in the medium. The apparent "sticki-
ness" of early passage populations may reflect important in vivo phenomena. These
could include tissue binding in tick and/or mammalian hosts and resistance to pha-
gocytosis through formation of these micro- and macrocolonies.
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